Related Experiment Video
Updated: Mar 15, 2026
07:54
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
10.5K
Methionine enkephalin regulates microglia polarization and function
1Department of Neurology, Shengjing Hospital, Affiliated Hospital of China Medical University, Shenyang 110004, PR China.
International Immunopharmacology
|September 2, 2016
Summary
Methionine enkephalin (MENK) promotes microglia to an M1 phenotype, enhancing their tumoricidal activity against glioblastoma. This opioid peptide shows potential for modulating anti-tumor immunity in the central nervous system.
Area of Science:
- Neuroimmunology
- Cancer Immunology
Background:
- Microglia are key immune cells in the central nervous system (CNS).
- Methionine enkephalin (MENK) is an opioid peptide that regulates immune responses.
Purpose of the Study:
- To investigate the effect of MENK on microglia polarization.
- To assess MENK's impact on microglia's tumoricidal responses against glioblastoma.
Main Methods:
- Treatment of microglia with MENK (10-12M for 48h).
- Analysis of M1/M2 marker gene expression (CD86, CD40, IL-12, TNF-α, CD163, IL-10, TGF-β).
- Assessment of phagocytosis, reactive oxygen species (ROS), nitric oxide (NO) production, and cytotoxicity against glioblastoma cells.
Main Results:
- MENK induced an M1 microglia phenotype, upregulating M1 markers and phagocytosis.
- MENK increased ROS and NO production (via iNOS) without affecting M2 markers or arginase-1.
- MENK-treated microglia exhibited significant cytotoxicity against glioblastoma cells.
Conclusions:
- MENK drives microglia towards an M1 phenotype, enhancing anti-tumor immunity.
- MENK demonstrates potential as a therapeutic agent for glioblastoma by activating microglia-mediated tumoricidal activity.
